SLC2A5 and acute myeloid leukemia: Finally, inhibiting fructose metabolism in AML cells with in vitro and in vivo models with 2,5-anhydro-D-mannitol (2,5-AM), a fructose analog with high affinity to GLUT5, demonstrated therapeutic potential (46).